No abstract

Four trihalomethanes were administered by gavage to Sprague-Dawley rats from day 6 to day 15 of gestation. Chloroform (Ch) was administered at levels of 100, 200 and 400 mg/kg and bromoform (Br), bromodichloromethane (BDCM) and chlorodibromomethane (CDBM) were administered at levels of 50, 100 or 200 mg/kg/day. A separate control was used for each compound. Maternal weight gain was depressed in all groups receiving Ch and at the highest dose levels of BDCM and CDBM. Ch administration caused decreased maternal hemoglobin and hematocrit values at all dose levels and also produced increased serum inorganic phosphorus and cholesterol at the highest dose. Liver enlargement was observed at all dose levels of Ch but in no other treatment groups. Evidence of a fetotoxic response was observed with Ch, CDBM and Br but not BDCM. No dose-related histopathological changes were observed in either mothers or fetuses as a result of treatment. None of the chemicals tested produced any teratogenic effects.

A teratological assessment was performed using rats that were exposed to an alternating magnetic field. The magnetic field had a sawtooth waveform similar to that produced by video display terminals (VDTs). Female rats were exposed 2 weeks prior to and throughout pregnancy at a rate of 7 h/day. Three intensities of magnetic field (5.7, 23 or 66 microT) were used. All of these field intensities were much greater than those to which VDT users are exposed. A slight but statistically significant decrease in maternal lymphocyte count for the highest intensity field was found as compared with the control group. However, the lymphocyte count was within the normal range, and the observed changes in hematological parameters were considered mild. No other maternal or fetal parameters that were examined showed a significant difference for any of the three field intensities. Where minor variations in skeleton development were observed they were known to be the common "noise" that appears in every teratological evaluation.

No abstract

Single oral administration to rats of 240 mg/kg ethylenethiourea on days 10-21 of gestation produced visceral anomalies involving the nervous, urogenital, and ocular systems, and osseous anomalies affecting the axial and appendicular skeletons. The types of anomalies and organs affected were dependent on the stage of prenatal development at the time of treatment.